One-Liner
A data subscription telling US/EU biotech clinical operations teams when and where MENA clinical site capacity exists per therapeutic area, alongside regulatory and ethics committee turnaround benchmarks.
AI Thinking Process
Oncology = 38% of all drugs in development → site-capacity scarcity for non-oncology sponsors in US/EU. MENA region has growing medical infrastructure and underutilized clinical capacity.
Clinical ops director at US/EU non-oncology biotech competes for oncology-saturated US sites, runs 12–24 months over enrollment, considers MENA via consultants at $50–150K per country feasibility study.
Verb Transplant: 'marketplace liquidity' from financial markets → clinical trial site capacity. Structured site-capacity exchange for MENA.
Marketplace without local regulatory operations is illusion. With local ops = service business, not SaaS.
Pivot: abandon MENA marketplace, sell MENA + LATAM site-capacity intelligence subscription at $50–150K/year. Data product, no local regulatory ops required.
Pivot conviction 45% — below 50% threshold. ~200 US/EU biotechs × 30% who consider non-US sites = ~60 accounts. Narrow buyer list + slow data sources. Confirmed killed.
Kill Reason
Narrow buyer pool (~60 accounts after filtering), data freshness depends on slow public scraping and trade press in Arabic/Turkish/Portuguese requiring a translation stack. Conviction ceiling 45% even after pivot from marketplace illusion to data subscription.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: Narrow buyer pool (~60 accounts after filtering), data freshness depends on slow public scraping and trade press in Arabic/Turkish/Portuguese requiring a translation stack. Conviction ceiling 45% even after pivot from marketplace illusion to data subscription.
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.